77779193永利(中国集团)有限公司-Game starts

Your privacy is very important to us.When you visit our website,please agree to the use of all cookies.For more information about personal data processing,please go t0 《Privacy Policy Statement》

中
En
About Us
Overview
Founder
Platform
Milestones
Culture
Honors
Core Technology
Technological platforms
Pipeline
Academic achievements
Clinical Trials
News
Company News
Media News
Join Us
Social Recruitment
Campus Recruitment
Contact
xinwen.jpg pcxinwendongtai.jpg

News
Company News
ScreenShot_2025-11-21_103358_653.png
SITC 2025 | Single Intravenous Infusion Leads to Complete Eradication of High-Grade Glioblastoma in 4 Weeks

2025.11.21
Learen More +
tupian11.png
Juncell Therapeutics Announces Data on Feeder-free IL-2-Independent TIL Manufacturing Process at ASGCT Annual Meeting 2025

2025.04.29
Learen More +
tupian1-637.png
Juncell Therapeutics to Present Preclinical Data on Innovative Pretreatment Regimen of TIL Therapy at AACR Annual Meeting 2025

2025.03.26
Learen More +
tupian11.png
Juncell Therapeutics Announces A Phase II Study Using GC101 TIL in Melanoma

2024.12.05
Learen More +
tupian1.png
Juncell Therapeutics Announces A Phase Ib Study Using GC101 TIL in Non-Small Cell Lung Cancer

2024.10.14
Learen More +
wangzhan-zhutu.png
Celebrating 5 Years of Juncell Therapeutics

2024.06.27
Learen More +
XML 地图